Is Disease Severity Greater Among Patients with Rheumatoid Arthritis Who Receive a Newly Approved Biologic? Real-world US Experience with Sarilumab from the ACR RISE Registry

被引：0
|
作者：
Fiore, Stefano [1 ]
Chen, Lang [2 ]
Clinton, Cassie [2 ]
Yun, Huifeng [2 ]
Praestgaard, Amy [3 ]
Ford, Kerri [3 ]
Curtis, Jeffrey R. [2 ]
机构：
[1] Sanofi, Bridgewater, NJ USA
[2] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[3] Sanofi, Cambridge, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0834
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Disease severity and outcomes among patients with rheumatoid arthritis who receive a newly approved biologic: Real-world US experience with Sarilumab from the ACR RISE registry
    Curtis, Jeffrey R.
    Fiore, Stefano
    Chen, Lang
    Clinton, Cassie
    Yun, Huifeng
    Praestgaard, Amy
    Ford, Kerri
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 645 - 645
  • [2] DISEASE SEVERITY AND OUTCOMES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS WHO RECEIVE A NEWLY APPROVED BIOLOGIC: REAL-WORLD US EXPERIENCE WITH SARILUMAB FROM THE ACR RISE REGISTRY
    Fiore, S.
    Chen, L.
    Clinton, C.
    Yun, H.
    Praestgaard, A.
    Ford, K.
    Curtis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 556 - 557
  • [3] Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
    Curtis, Jeffrey R.
    Yun, Huifeng
    Chen, Lang
    Ford, Stephanie S.
    van Hoogstraten, Hubert
    Fiore, Stefano
    Ford, Kerri
    Praestgaard, Amy
    Rehberg, Markus
    Choy, Ernest
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 1055 - 1072
  • [4] Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
    Jeffrey R. Curtis
    Huifeng Yun
    Lang Chen
    Stephanie S. Ford
    Hubert van Hoogstraten
    Stefano Fiore
    Kerri Ford
    Amy Praestgaard
    Markus Rehberg
    Ernest Choy
    Rheumatology and Therapy, 2023, 10 : 1055 - 1072
  • [5] Real World Validation of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis: Analysis from the RISE Registry
    Yun, Huifeng
    Curtis, Jeffrey
    Chen, Lang
    Clinton, Cassie
    van Hoogstraten, Hubert
    Fiore, Stefano
    Rehberg, Markus
    Choy, Ernest
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2568 - 2570
  • [6] Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
    Jeffrey R. Curtis
    Huifeng Yun
    Lang Chen
    Stephanie S. Ford
    Hubert van Hoogstraten
    Stefano Fiore
    Kerri Ford
    Amy Praestgaard
    Markus Rehberg
    Ernest Choy
    Rheumatology and Therapy, 2024, 11 (1) : 217 - 217
  • [7] BASELINE RHEUMATOID ARTHRITIS SEVERITY AMONG PATIENTS RECEIVING BIOLOGIC DMARDS: FINDINGS FROM A REAL-WORLD DATABASE
    Chan, C.
    Starzyk, K.
    Richards, C.
    Gliklich, R.
    Menzin, J.
    VALUE IN HEALTH, 2019, 22 : S433 - S433
  • [8] REAL-WORLD EFFECTIVENESS OF TNFI VERSUS NON-TNFI BIOLOGICS ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE ACR'S RISE REGISTRY
    Gianfrancesco, M.
    Li, J.
    Evans, M.
    Petersen, M.
    Schmajuk, G.
    Yazdany, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 65 - 66
  • [9] Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
    John Tesser
    Iris Lin
    Natalie J. Shiff
    Soumya D. Chakravarty
    Gabriela Schmajuk
    Nevin Hammam
    Sheetal Desai
    Clinical Rheumatology, 2022, 41 : 2319 - 2327
  • [10] Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
    Tesser, John
    Lin, Iris
    Shiff, Natalie J.
    Chakravarty, Soumya D.
    Schmajuk, Gabriela
    Hammam, Nevin
    Desai, Sheetal
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2319 - 2327
12345